Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06880679 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ultrasound Acute Chest Syndrome Sickle Cell Disease

Study acronym: POCUS
StatusCompleted
PhaseNot applicable
Started2025-04-08
View on ClinicalTrials.gov ↗

Amendment history

2026-08-31
Study Status, Study Design, Contacts/Locations v4
Trial completed
Final enrollment: 27 participants (planned 30)
Primary completion confirmed: May 2026 (last estimated June 2026)
Primary completion dateestimated 2026-06-30→confirmed 2026-05-06
Completion dateestimated 2026-06-30→confirmed 2026-05-06
Enrollment targetestimated 30→confirmed 27
Study sitesdetails revised at 1 of 1 site
2026-04-06
Study Status, Oversight v3
Primary completion date2026-03-01→2026-06-30
Completion date2026-03-01→2026-06-30
2025-04-09
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-03-17→confirmed 2025-04-08
Study sitesdetails revised at 1 of 1 site
2025-03-17
Study Identification, Study Status, Oversight, Outcome Measures v1
Re-verified, no change to tracked fields
2025-03-14
Original filing
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Trial Details
NCT Number NCT06880679
Lead Sponsor Indiana University
Conditions Acute Chest Syndrome, Sickle Cell Disease
Enrollment 27 participants
Start Date 2025-04-08
Primary Completion 2026-05-06 (estimated)
Study Completion 2026-05-06 (estimated)
Updated on ClinicalTrials.gov 2026-09-02